Journal
CELL REPORTS
Volume 30, Issue 2, Pages 555-+Publisher
CELL PRESS
DOI: 10.1016/j.celrep.2019.12.045
Keywords
-
Categories
Funding
- Fondation Leducq (Transatlantic Network of Excellence Awards)
- National Institutes of Health (NIH) [R01HL135093, R01GM114434, T32HL007824, R01HL130423]
- Fondation Leducq [15 CVD 03, 13 CVD 01]
- National Health and Medical Research Council of Australia (NHMRC) [APP1118576, 1074386]
- Australian Research Counsel Special Initiative in Stem Cell Science [SR110001002]
- New South Wales Government Department of Health
- Progeria Research Foundation
Ask authors/readers for more resources
PDGFR alpha(+)mesenchymal progenitor cells are associated with pathological fibro-adipogenic processes. Conversely, a beneficial role for these cells during homeostasis or in response to revascularization and regeneration stimuli is suggested, but remains to be defined. We studied the molecular profile and function of PDGFR alpha(+) cells in order to understand the mechanisms underlying their role in fibrosis versus regeneration. We show that PDGFR alpha(+) cells are essential for tissue revascularization and restructuring through injury-stimulated remodeling of stromal and vascular components, context-dependent clonal expansion, and ultimate removal of pro-fibrotic PDGFR alpha(+)-derived cells. Tissue ischemia modulates the PDGFR alpha(+) phenotype toward cells capable of remodeling the extracellular matrix and inducing cell-cell and cell-matrix adhesion, likely favoring tissue repair. Conversely, pathological healing occurs if PDGFR alpha(+)-derived cells persist as terminally differentiated mesenchymal cells. These studies support a context-dependent yin-yang biology of tissue-resident mesenchymal progenitor cells, which possess an innate ability to limit injury expansion while also promoting fibrosis in an unfavorable environment.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available